A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
收藏DataCite Commons2025-10-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00007575/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The main purpose of this study is to evaluate the safety and efficacy of the study drug known
as ixekizumab in biological disease-modifying anti-rheumatic drugs (bDMARDs)-naive
participants with radiographic axial spondyloarthritis (rad-axSpA).
提供机构：
Vivli
创建时间：
2021-12-23
